Patent Ductus Arteriosus Treatment in Very Preterm Infants: A European Population-Based Cohort Study (EPICE) on Variation and Outcomes

Publisher： Karger

E-ISSN： 1661-7819|111|4|367-375

ISSN： 1661-7800

Source： Neonatology, Vol.111, Iss.4, 2017-01, pp. : 367-375

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Timing of Pharmacological Treatment for Patent Ductus Arteriosus and Risk of Secondary Surgery, Death or Bronchopulmonary Dysplasia: A Population-Based Cohort Study of Extremely Preterm Infants

By  

Neonatology, Vol. 107, Iss. 2, 2014-11 ,pp. : 87-92

Karger

Access to resources Recommend Favorite

Minimal Effective Dose of Indomethacin for the Treatment of Patent Ductus arteriosus in Preterm Infants

By  

Neonatology, Vol. 81, Iss. 2, 2002-02 ,pp. : 91-94

Karger

Access to resources Recommend Favorite

Neurodevelopmental Outcome at 2 Years of Age according to Patent Ductus Arteriosus Management in Very Preterm Infants

By  

Neonatology, Vol. 109, Iss. 2, 2016-0 ,pp. : 139-146

Karger

Access to resources Recommend Favorite

Platelet Counts in the First Seven Days of Life and Patent Ductus Arteriosus in Preterm Very Low-Birth-Weight Infants

By  

Neonatology, Vol. 106, Iss. 3, 2014-07 ,pp. : 188-194

Karger

Access to resources Recommend Favorite

Indomethacin Treatment of Patent Ductus Arteriosus in Premature Infants

By McIntyre John   Van Overmeire Bart   van den Anker John N.  

Paediatric and Perinatal Drug Therapy, Vol. 4, Iss. 3, 2001-06 ,pp. : 85-91

Informa Healthcare

Access to resources Recommend Favorite